查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017760

美國抗菌導管市場規模、佔有率和趨勢分析報告：按產品類型、技術、材料、最終用途和細分市場預測，2026-2033年

U.S. Antimicrobial Catheters Market Size, Share & Trends Analysis Report By Product Type, By Technology, By Material, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國抗菌導管市場概述

據估計，2025年美國抗菌導管市值為5.0618億美元，預計到2033年將達到9.3244億美元，2026年至2033年的複合年成長率為7.94%。

此市場成長的主要促進因素是醫院感染率上升、急診和長期照護機構的導管插入增加，以及臨床上對感染預防和病人安全的日益重視。

在美國，每年進行超過一百萬例心臟導管介入手術。此外，抗菌塗層醫療設備的日益普及、感染控制指南的製定以及對先進醫療技術投入的增加，都進一步推動了市場成長。

中央靜脈導管相關血流感染 (CLABSI)、導尿管相關尿道感染(CAUTI) 和人工呼吸器相關事件 (VAE) 是美國抗菌導管市場的主要促進因素。這些感染是院內感染 (HAI) 的主要負擔，並給醫療系統帶來了越來越大的臨床和經濟壓力，迫使其採用感染預防技術​​。這些醫療設備相關感染疾病的高發生率促使醫院優先採用抗菌塗層和藥物釋放型導管技術，以降低微生物定植和感染的風險。研究表明，抗菌塗層導管可以減少微生物定植，這直接促進了醫院感染控制計畫的實施，並推動了採購轉向塗層產品。此外，隨著院內感染整體的增加，醫院擴大將塗層導管的使用作為感染控制方案的一部分，從而推動了重症監護室 (ICU)、外科手術和長期護理機構對抗菌導管產品的需求。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國抗菌導管市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國抗菌導管市場分析工具

第4章：美國抗菌導管市場：依產品類型分類的估算與趨勢分析

  • 美國抗菌導管市場：按產品類型分類的波動分析
  • 美國抗菌導管市場：依產品類型分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 泌尿系統
  • 血管通路導管
  • 特殊和外科導管

第5章：美國抗菌導管市場：依技術分類的估算與趨勢分析

  • 美國抗菌導管市場：基於技術的波動分析
  • 美國抗菌導管市場：依技術分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 銀技術
  • 抗生素浸漬型
  • 有機/聚合物基（非金屬/非抗菌）
  • 複合材料技術

第6章：美國抗菌導管市場：依材料分類的估算與趨勢分析

  • 美國抗菌導管市場：基於材料的波動分析
  • 美國抗菌導管市場：按材料和前景分類
  • 市場規模、預測與趨勢分析，2021-2033年
  • 矽酮
  • 聚氨酯（PU）
  • 乳膠
  • 其他

第7章：美國抗菌導管市場：依最終用途分類的估算與趨勢分析

  • 美國抗菌導管市場：依最終用途分類的波動分析
  • 美國抗菌導管市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院
  • 長期照護機構（LTC）
  • 居家照護
  • 門診手術中心（ASC）
  • 其他

第8章 競爭情勢

  • 參與企業的分類
  • 2025年企業市場占有率分析
  • 主要企業簡介
    • B. Braun SE
    • Teleflex Incorporated
    • SilvoGuard
    • BD
    • MEDLINE
    • ConvaTec Group PLC
    • Silq Technologies
    • AvantGuard（Halomine Inc.）
    • Medtronic
    • Cook
    • Integra LifeSciences Corporation
    • Vygon
    • Camstent
Product Code: GVR-4-68040-868-8

U.S. Antimicrobial Catheters Market Summary

The U.S. antimicrobial catheters market size was estimated at USD 506.18 million in 2025 and is projected to reach USD 932.44 million by 2033, growing at a CAGR of 7.94% from 2026 to 2033. The growth of this market is primarily driven by the rising incidence of hospital-acquired infections, the increasing number of catheterization procedures across acute and long-term care settings, and the growing clinical focus on infection prevention and patient safety.

More than 1 million cardiac catheterization procedures are performed every year in the U.S. In addition, expanding adoption of antimicrobial-coated devices, supportive infection control guidelines, and increasing healthcare investments in advanced medical technologies are further supporting market expansion.

CLABSI (central line-associated bloodstream infections), CAUTI (catheter-associated urinary tract infections), and VAE (ventilator-associated events) are major drivers of the U.S. antimicrobial catheters market. They represent the primary hospital-acquired infection (HAI) burden, increasing clinical and economic pressure on healthcare systems to adopt infection-prevention technologies. High incidence of these device-associated infections leads hospitals to prioritize antimicrobial-coated and drug-eluting catheter technologies to reduce microbial colonization and infection risk. Studies show that antimicrobial-coated catheters can reduce microbial colonization, which directly supports hospital infection reduction programs and procurement shifts toward coated devices. In addition, the broader rise in HAIs has led hospitals to increasingly standardize the use of coated catheters as part of infection control protocols, reinforcing demand for antimicrobial catheter products across ICU, surgical, and long-term care settings.

U.S. Antimicrobial Catheters Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. antimicrobial catheters market report on the basis of product type, technology, material, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Urological Catheters
  • Vascular Access Catheters
  • Specialty and Surgical Catheters
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Silver-Based Technology
  • Antibiotic-Impregnated
  • Organic/Polymer-Based (Non-Metal/Non-Antibiotic)
  • Combination Technologies
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Silicone
  • Polyurethane (PU)
  • Latex
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Long-Term Care Facilities (LTCs)
  • Home Care
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product Type
    • 1.1.2. Technology
    • 1.1.3. Material
    • 1.1.4. End Use
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Antimicrobial Catheters Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of Healthcare-associated Infections (HAIs)
      • 3.2.1.2. Increasing surgical procedures and hospital admissions
      • 3.2.1.3. Growing aging population with higher catheterization needs
      • 3.2.1.4. Advancements in antimicrobial coating technologies
      • 3.2.1.5. Increasing awareness about catheter-associated infection risks
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Higher cost of antimicrobial catheters compared to standard catheters
      • 3.2.2.2. Strict regulatory approval processes
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of home healthcare and ambulatory care settings
      • 3.2.3.2. Development of non-antibiotic antimicrobial technologies
      • 3.2.3.3. Increasing investments in healthcare infrastructure
      • 3.2.3.4. Rising focus on reducing hospital stay duration and readmissions
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Pricing pressure from healthcare providers and procurement bodies
      • 3.2.4.2. Need for continuous innovation to address resistant pathogens
  • 3.3. U.S. Antimicrobial Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Reimbursement Scenario

Chapter 4. U.S. Antimicrobial Catheters Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Antimicrobial Catheters Market: Product Type Movement Analysis
  • 4.3. U.S. Antimicrobial Catheters Market by Product Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Urological Catheters
    • 4.5.1. Urological Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Vascular Access Catheters
    • 4.6.1. Vascular Access Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Specialty and Surgical Catheters
    • 4.7.1. Specialty and Surgical Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Antimicrobial Catheters Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Antimicrobial Catheters Market: Technology Movement Analysis
  • 5.3. U.S. Antimicrobial Catheters Market by Technology Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Silver-Based Technology
    • 5.5.1. Silver-Based Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Antibiotic-Impregnated
    • 5.6.1. Antibiotic-Impregnated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Organic/Polymer-Based (Non-Metal/Non-Antibiotic)
    • 5.7.1. Organic/Polymer-Based (Non-Metal/Non-Antibiotic) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Combination Technologies
    • 5.8.1. Combination Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Antimicrobial Catheters Market: Material Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Antimicrobial Catheters Market: Material Movement Analysis
  • 6.3. U.S. Antimicrobial Catheters Market by Material Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Silicone
    • 6.5.1. Silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Polyurethane (PU)
    • 6.6.1. Polyurethane (PU) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latex
    • 6.7.1. Latex Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Antimicrobial Catheters Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Antimicrobial Catheters Market: End Use Movement Analysis
  • 7.3. U.S. Antimicrobial Catheters Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Long-Term Care Facilities (LTCs)
    • 7.6.1. Long-Term Care Facilities (LTCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Care
    • 7.7.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Ambulatory Surgery Centers (ASCs)
    • 7.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Share Analysis, 2025
  • 8.3. Key Company Profiles
    • 8.3.1. B. Braun SE
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Teleflex Incorporated
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. SilvoGuard
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MEDLINE
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. ConvaTec Group PLC
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Silq Technologies
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. AvantGuard (Halomine Inc.)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Medtronic
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Cook
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Integra LifeSciences Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Vygon
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Camstent
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. antimicrobial catheters, by product type, 2021 - 2033 (USD Million)
  • Table 4. U.S. antimicrobial catheters, by technology, 2021 - 2033 (USD Million)
  • Table 5. U.S. antimicrobial catheters, by material, 2021 - 2033 (USD Million)
  • Table 6. U.S. antimicrobial catheters, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Antimicrobial Catheters Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 U.S. Antimicrobial Catheters Market, Product Type Outlook Key Takeaways (USD Million)
  • Fig. 12 U.S. Antimicrobial Catheters Market, Product Type Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 13 Urological Catheters Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Vascular Access Catheters Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Specialty and Surgical Catheters Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Antimicrobial Catheters Market, Technology Outlook Key Takeaways (USD Million)
  • Fig. 17 U.S. Antimicrobial Catheters Market Technology Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 18 Silver-Based Technology Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Antibiotic-Impregnated Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Organic/Polymer-Based (Non-Metal/Non-Antibiotic) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Combination Technologies Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Antimicrobial Catheters Market, Material Outlook Key Takeaways (USD Million)
  • Fig. 23 U.S. Antimicrobial Catheters Market Material Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 24 Silicone Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Polyurethane (PU) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Latex Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Antimicrobial Catheters Market, End Use Outlook Key Takeaways (USD Million)
  • Fig. 30 U.S. Antimicrobial Catheters Market End Use Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 31 Hospitals Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Long-Term Care Facilities (LTCs) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Home Care Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Ambulatory Surgery Centers (ASCs) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)